Japan’s Riken Reboots After Stem-Cell Scandal – NASDAQ
|
Japan's Riken Reboots After Stem–Cell Scandal
NASDAQ Riken's overhaul could also sway the field of stem–cell science, which has received billions of dollars in research funds in the hopes of cures for ailments such as diabetes and heart disease. Some details of the overhaul, including whether anyone … |
